Free Trial

Zevia PBC (NYSE:ZVIA) Announces Quarterly Earnings Results

Zevia PBC logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Zevia beat revenue expectations in the quarter, reporting $46.09 million in sales versus the $40.97 million consensus estimate, while EPS came in at $(0.03) and matched forecasts.
  • The company highlighted strong Q1 growth and brand momentum, including 21.2% net sales growth, a Cardi B marketing partnership, and improved product packaging and innovation that are helping drive distribution gains.
  • Despite the upbeat quarter, cost pressures are weighing on margins: gross margin fell and Zevia cut its 2026 outlook to $170–$175 million in net sales with adjusted EBITDA projected at negative $2 million to negative $4 million.
  • Interested in Zevia PBC? Here are five stocks we like better.

Zevia PBC (NYSE:ZVIA - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.03) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.03), FiscalAI reports. Zevia PBC had a negative net margin of 4.11% and a negative return on equity of 13.22%. The company had revenue of $46.09 million during the quarter, compared to the consensus estimate of $40.97 million.

Here are the key takeaways from Zevia PBC's conference call:

  • Zevia reported a strong Q1 with 21.2% net sales growth to $46.1M and adjusted EBITDA of about $0.9M, both above expectations.
  • Management is leaning into a major marketing push—including a new Cardi B partnership and two brand campaigns—that generated record organic social reach and engagement.
  • Product innovation and packaging refresh (new fruit flavors and improved taste) are rolling out, with management saying the new packaging should be largely on shelves by end of Q2 and early velocity/​incrementality results above median at key retailers.
  • Distribution momentum continued with a national Costco rotation, Walmart chain and Canadian expansion, club channel entries, and strong e‑commerce performance, which management expects will broaden household penetration.
  • Rising input and fuel costs pressured gross margin (down 170 bps to 48.4%) and prompted a revised 2026 outlook of net sales $170–$175M but adjusted EBITDA of negative $2M to negative $4M due to an ~$11M incremental cost headwind.

Zevia PBC Stock Performance

Shares of NYSE:ZVIA traded up $0.17 during midday trading on Friday, reaching $1.47. The company had a trading volume of 1,010,879 shares, compared to its average volume of 469,304. Zevia PBC has a 1-year low of $1.11 and a 1-year high of $3.66. The firm has a market cap of $110.02 million, a price-to-earnings ratio of -14.65 and a beta of 0.95. The company has a fifty day simple moving average of $1.26 and a two-hundred day simple moving average of $1.88.

Insider Transactions at Zevia PBC

In other Zevia PBC news, CFO Girish Satya sold 41,662 shares of the business's stock in a transaction dated Wednesday, March 25th. The stock was sold at an average price of $1.18, for a total transaction of $49,161.16. Following the sale, the chief financial officer owned 327,909 shares in the company, valued at approximately $386,932.62. The trade was a 11.27% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 11.11% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in ZVIA. Quadrature Capital Ltd purchased a new stake in shares of Zevia PBC in the 4th quarter valued at approximately $26,000. Engineers Gate Manager LP purchased a new position in Zevia PBC during the 4th quarter worth approximately $28,000. The Manufacturers Life Insurance Company acquired a new stake in Zevia PBC during the 4th quarter valued at $38,000. Tocqueville Asset Management L.P. acquired a new stake in Zevia PBC during the 3rd quarter valued at $44,000. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Zevia PBC by 2,460.7% in the second quarter. JPMorgan Chase & Co. now owns 15,518 shares of the company's stock valued at $50,000 after purchasing an additional 14,912 shares in the last quarter. 53.21% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ZVIA. Weiss Ratings reiterated a "sell (d-)" rating on shares of Zevia PBC in a report on Monday, April 20th. Telsey Advisory Group reduced their target price on shares of Zevia PBC from $6.00 to $5.00 and set an "outperform" rating for the company in a report on Thursday, February 26th. Finally, Craig Hallum started coverage on shares of Zevia PBC in a research report on Thursday, January 15th. They issued a "buy" rating and a $4.00 price target on the stock. Three analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, Zevia PBC presently has a consensus rating of "Hold" and a consensus price target of $4.43.

View Our Latest Stock Analysis on ZVIA

About Zevia PBC

(Get Free Report)

Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia's mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.

The company's product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.

Read More

Earnings History for Zevia PBC (NYSE:ZVIA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Zevia PBC Right Now?

Before you consider Zevia PBC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zevia PBC wasn't on the list.

While Zevia PBC currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines